久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

  Home>News Center>Life
         
 

Cheap AIDS pill as good as pricey brands
(Agencies)
Updated: 2004-07-03 10:21

A cheap three-in-one generic AIDS pill from India is just as good as more expensive branded medicines and should be widely used in developing countries, researchers said on Friday.

Lack of scientific evidence about the clinical effectiveness of such generic fixed-dose combinations has until now caused some international AIDS donors to refuse to fund their use.

But a team from the French national agency for AIDS research and Swiss charity Medecins sans Frontieres said Cipla's Triomune performed as well as brand drugs in the first open clinical study in a developing country.

They found that 80 percent of HIV-infected patients given the tablet twice a day had undetectable levels of virus in their blood after six months treatment.

Results of the study involving 60 patients in Cameroon, 92 percent of whom had full-blown AIDS, were published in The Lancet medical journal.

“This generic fixed-dose combination (FDC) gives results comparable to those seen in the developed world using triple-drug therapy comprising brand name drugs,” said study co-ordinator Eric Delaporte.

“It is now no longer possible to raise scientific uncertainty as an objection to the widespread utilization of FDCs in the developing countries.”

In addition to being cheaper, drugs like Triomune -- which contains GlaxoSmithKline's lamivudine, Bristol-Myers Squibb's stavudine and Boehringer Ingelheim's nevirapine -- are simpler to use since patients need to take only two pills a day.

As such, they have a major role to play in meeting the World Health Organization's goal of getting antiretrovirals to three million people in the developing world by the end of 2005, N. Kumarasamy of the YRG Centre for AIDS Research and Education in Madras wrote in a commentary accompanying the research.

Controversy remains

The WHO has judged Triomune and another Indian combination called Triviro, from Ranbaxy Laboratories, to be safe and effective under a scheme that “prequalifies” them for use.

But both products -- which use compounds still covered by patents -- remain controversial.

Washington has barred groups receiving U.S. government funds from buying them, insisting only drugs approved by the Food and Drug Administration be used.

U.S. officials and Western pharmaceutical executives argue health providers are taking a risk by using medicines which have not passed the rigorous standards of the U.S. drugs watchdog.

Worries about the quality of Indian medicines were fuelled last month when the WHO removed two Cipla products -- though not Triomune -- from its prequalification list because they had not been proven to be equivalent to the original products.

Cipla says it is collecting data from new studies which should lead to the drugs being re-instated.

In Cameroon, where drugs are subsidized by the government, the cost of one month’s Triomune is $20, compared to $35 for the equivalent brand name therapy, even after heavy discounting by big pharmaceutical companies.

Elsewhere, cost differences can vary by as much as 100 percent, according to Medecins sans Frontieres.



Jackie Chan's new film 'The Myth'
CK over the top
Stephen Chow's kong fu to hit Mainland cinemas
  Today's Top News     Top Life News
 

Stress kills workaholic academics at young age

 

   
 

Efforts urged to curb floods, drought

 

   
 

China opposes foreign interference in HK

 

   
 

Ministry battles telecom price wars

 

   
 

UK indicts three in shell-fish drownings

 

   
 

Migrant workers given classes on AIDS

 

   
  Marlon Brando dies in Los Angeles hospital
   
  Apple plans new iMac, but delays shipment until Sept
   
  Fragrance makers hook up with Hollywood stars
   
  Piano maker tunes into China's growing middle class
   
  Nation hurries to salvage undersea cultural relics
   
  Panda smokes draw a crowd
   
 
  Go to Another Section  
 
 
  Story Tools  
   
  Feature  
  Oops! Britney to do marriage again  
Advertisement
         
主站蜘蛛池模板: 日本一区二区三区四区无限 | 欧美极品第1页专区 | 99国产精品久久久久久久日本 | 国产免费福利体检区久久 | 久久香蕉国产精品一区二区三 | 欧美一区二区视频在线观看 | 青青热在线精品视频免费 | 亚洲国产2017男人a天堂 | 久久精品免费观看久久 | 日韩亚洲欧美综合一区二区三区 | 国产成人禁片免费观看视频 | 成在线人视频免费视频 | 黄 色 成 年 人小说 | 久久青草网站 | 久久精品最新免费国产成人 | 精品视频一区二区 | 成人国产片免费 | 国产亚洲一区二区手机在线观看 | 欧美成人高清手机在线视频 | 国产日韩欧美swag在线观看 | 日本久久久久久 | 久久精品国产国产精品四凭 | 99精品免费在线 | 亚洲二区在线观看 | 欧美在线国产 | 国产真实乱子伦xxxxchina | 日本特黄特色免费大片 | 国产午夜毛片v一区二区三区 | 美女张开腿男人桶 | 欧美成人猛男性色生活 | 国模偷拍在线观看免费视频 | 欧美视频在线看 | 免费在线观看一区 | 国产毛片一级 | 国产一区视频在线 | 欧美日韩亚洲综合久久久 | 三级全黄视频 | a毛片视频免费观看影院 | 欧美精品午夜毛片免费看 | 中文字幕日韩精品亚洲七区 | 成人观看免费大片在线观看 |